SOURCE: DC Brands International, Inc.

April 23, 2008 16:28 ET

DC Brands: It's Go Time

DENVER, CO--(Marketwire - April 23, 2008) - Today DC Brands International, Inc. (PINKSHEETS: DCBR) announced they will have their Chief Procurement Officer, Jeremy Alcamo, travel to Wisconsin to oversee the first production run of their much anticipated H.A.R.D. Nutrition Functional Water Systems. Mr. Alcamo said, "We will start running about 5:00am Monday morning. We will run our Wide Awake first to ensure all of the improvements and enhancements to the production line we invested in are working properly. We expect no problems. Once all tests are complete, we will move on to our Whacked Energy, Get Over It-Hang Over Relief, Fat Fighter and then on to our other products. It is going to take three full runs just to deliver on our backordered presales; however, by this time next month, we expect to be caught up and into a smooth production and delivery mode."

About DC Brands International:

DC Brands International, a publicly traded company under the ticker symbol (PINKSHEETS: DCBR), specializes in and manufactures unique energy drink brands and health products. Established in 1998, DC Brands went public in 2005, and the company's first product, Dickens Energy Cider, launched in 2002 after a lengthy process in developing its distinctive flavor and packaging. Following the success of Dickens Energy Cider, the company chose to expand its product line with introduction of Turn Left Energy Drink that filled the substantial NASCAR niche. In 2007, DC Brands purchased the assets of HARD Nutrition and began its quest to produce a new health line of products. DC Brands is now poised to release their new HARD Nutrition Functional Water Systems in the spring of 2008.

For more information on DC Brands International, visit their website at and

Note: Except for the historical information contained herein, this news release contains forward-looking statements that involve substantial risks and uncertainties. Among the factors that could cause actual results or timelines to differ materially are risks associated with research and clinical development, regulatory approvals, supply capabilities and reliance on third-party manufacturers, product commercialization, competition, litigation, and the other risk factors listed from time to time in reports filed by DC Brands International with the Securities and Exchange Commission, including but not limited to risks described under the caption "Important Factors That May Affect Our Business, Our Results of Operation and Our Stock Price." The forward-looking statements contained in this news release represent judgments of the management of DC Brands International as of the date of this release. DC Brands International and its managers and agents undertake no obligation to publicly update any forward-looking statements.

Contact Information